bioRxiv Science⌕ Search

Biology subjects

Tamargo, M.

Publications and source records attributed to Tamargo, M..

2 recordsLinked to original sources

ASPECT: Alternative Splicing Event Classification with Transformers

MotivationAlternative splicing (AS) is a fundamental regulatory mechanism that expands transcriptomic and proteomic diversity by generating multiple mRNA isoforms from a single gene. Aberrant AS has been implicated in numerous diseases through the production of dysfunctional or pathogenic protein variants. However, much of the existing AS research has focused predominantly on exon skipping and constitutive splicing, with comparatively limited attention to other biologically relevant AS event types. Moreover, many current computational approaches rely on short genomic sequence windows and conventional deep learning architectures, which may limit their ability to capture broader regulatory context associated with complex splicing decisions. Bridging these methodological and conceptual gaps is essential for advancing comprehensive AS characterization and improving our understanding of its role in human health and disease. ResultsWe present ASPECT, an alternative splicing event classification framework built upon DNABERT-2 with Byte Pair Encoding (BPE) tokenization. Across multiple binary alternative splicing event pair classification tasks, ASPECT achieves consistently strong performance as measured by AUC, F1-score,and accuracy, demonstrating reliable discrimination between closely related splicing event types. Importantly, ASPECT demonstrates consistent performance when applied to TCGA BRCA cancer-associated splicing events reconstructed from SpliceSeq annotations, supporting its applicability beyond the canonical splicing events used for training. AvailabilityThe open-source code, data, and detailed documentation used in this study are available at https://github.com/OluwadareLab/ASPECT. ContactOluwatosin.Oluwadare@unt.edu Supplementary informationN/A

bioinformatics↗

STK25 inhibits PKA signaling by phosphorylating PRKAR1A

In the heart, Protein Kinase A (PKA) is critical for activating calcium handling and sarcomeric proteins in response to beta adrenergic stimulation leading to increased myocardial contractility and performance. The catalytic activity of PKA is tightly regulated by regulatory subunits which inhibit the catalytic subunit until released by cAMP binding. Phosphorylation of Type II regulatory subunits promotes PKA activation, however the role of phosphorylation in Type I regulatory subunits remain uncertain. Here we utilized human induced pluripotent stem cell cardiomyocytes (iPSC-CM) to identify STK25 as a kinase of the Type Ia regulatory subunit PRKAR1A. Phosphorylation of PRKAR1A led to inhibition of PKA kinase activity and increased binding to the catalytic subunit in the presence of cAMP. Stk25 knockout in mice diminished Prkar1a phosphorylation, increased Pka activity and augmented contractile response to beta adrenergic stimulation. Together, these data support STK25 as a negative regulator of PKA signaling through phosphorylation of PRKAR1A.

physiology↗